Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates

Neurocrine Biosciences (NBIX) came out with quarterly earnings of $0.42 per share, missing the Zacks Consensus Estimate of$ 1.04 per share. This compares to loss of $0.79 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -59.62%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of$ 1.13 per share when it actually produced earnings of $1.44, delivering a surprise of 27.43%.Over the last four ...